Our Facilities

Experience our world-class facilities
built on compliance and innovation.

We are at the forefront of drug development, manufacturing, and clinical research, committed to delivering world-class services that adhere to the highest industry standards. Our state-of-the-art facilities reflect our dedication to innovation, quality, and operational excellence, providing comprehensive solutions at every stage of the pharmaceutical lifecycle. With five facilities equipped with world-class technology and two additional facilities currently in development, we are continually expanding our capabilities to meet the evolving needs of the industry.

Manufacturing Facility

Our manufacturing facility is equipped with cutting-edge machinery and technology, providing a versatile platform for both small- and large-scale production. With the capacity to handle diverse manufacturing needs, we specialize in producing both potent molecules and high-volume products.

Block A
Oncology Therapeutics

The oncology therapeutics block is globally accredited and equipped with advanced technology to produce potent oncology molecules, including those classified under OEL Class 5. With an annual capacity of 500 million units, we ensure high-quality manufacturing tailored to the unique needs of oncology treatments.

Block B
General Therapeutics

The general therapeutics block is globally accredited, featuring cutting-edge equipment to support the production of a wide range of pharmaceutical products. With an impressive capacity of 2 billion units annually, we deliver reliable and scalable manufacturing solutions for general therapeutic needs.

Key Features of Manufacturing Facility Include:

  • Advanced machinery and equipment that adhere to global quality and precision standards.
  • Scalable production capacity, catering to both bulk orders and large-volume needs.
  • Robust quality control systems to maintain consistency, safety, and efficacy throughout production.
  • Full compliance with GMP (Good Manufacturing Practices), aligning with global regulatory standards.

Clinical Facility

This facility is designed to provide a safe, controlled environment for conducting clinical studies, with a focus on delivering the highest levels of volunteer care and regulatory compliance. This facility is equipped to conduct phase I to phase IV clinical trials, providing a full spectrum of clinical research services.

Key features of clinical trials facility include:

  • 190 beds with flexibility to conduct multiple studies simultaneously.
  • Advanced data collection systems for real-time monitoring and accuracy.
  • Compliance with ICH-GCP (International Council for Harmonisation – Good Clinical Practice) standards.
  • Experienced medical and research team dedicated to trial management, patient safety, and adherence to regulatory requirements.

R&D Facility

Aizant’s analytical laboratory is equipped with the latest testing instruments and technology to support all aspects of pharmaceutical testing and research. This laboratory plays a crucial role in ensuring the quality, safety, and effectiveness of pharmaceutical products through comprehensive analysis.

Key features of analytical lab include:

  • State-of-the-art equipment for precise and accurate testing, including HPLC, GC, IR, UV, and more.
  • Capacity for both routine and specialized analysis, including raw material testing, stability studies, and finished product testing.
  • Certified staff with expertise in pharmacological and analytical testing methods.
  • Strict adherence to global regulatory standards including FDA, EMA, and other international accredited certifications.

Commitment to Quality and Safety

We are driven by our commitment to quality and safety at every stage of the process from manufacturing to clinical trials and analytical testing. All our facilities comply with the highest standards of safety, security, and regulatory compliance, ensuring that our clients can trust us with their most critical drug development needs.